JW (Cayman) Therapeutics Co. Ltd

HKEX:2126.HK

1.37 (HKD) • At close September 20, 2024
Bedrijfsnaam JW (Cayman) Therapeutics Co. Ltd
Symbool 2126.HK
Munteenheid HKD
Prijs 1.37
Beurswaarde 553,814,131
Dividendpercentage 0%
52-weken bereik 1.19 - 3.49
Industrie Biotechnology
Sector Healthcare
CEO Dr. Yiping Li M.D.
Website https://www.jwtherapeutics.com

An error occurred while fetching data.

Over JW (Cayman) Therapeutics Co. Ltd

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate

Vergelijkbare Aandelen

Mabpharm Limited logo

Mabpharm Limited

2181.HK

0.305 HKD

HBM Holdings Limited logo

HBM Holdings Limited

2142.HK

1.24 HKD

IVD Medical Holding Limited logo

IVD Medical Holding Limited

1931.HK

1.8 HKD

Modern Dental Group Limited logo

Modern Dental Group Limited

3600.HK

3.85 HKD

IntelliCentrics Global Holdings Ltd. logo

IntelliCentrics Global Holdings Ltd.

6819.HK

4.06 HKD

Abbisko Cayman Limited logo

Abbisko Cayman Limited

2256.HK

3.12 HKD

China Pioneer Pharma Holdings Limited logo

China Pioneer Pharma Holdings Limited

1345.HK

2.08 HKD

Immunotech Biopharm Ltd logo

Immunotech Biopharm Ltd

6978.HK

2.84 HKD

Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc.

9960.HK

1.22 HKD

Zhaoke Ophthalmology Limited logo

Zhaoke Ophthalmology Limited

6622.HK

1.37 HKD

Financiële Gegevens

Cijfers zijn in miljoenen (HKD)

Cijfers zijn in miljoenen (HKD)